Pluristem shines in stem cell trial for muscle injury

Damian Garde

Israel's Therapeutics is back in the spotlight with some positive results for its therapy in treating patients with a , giving the biotech some good news in its up-and-down development path.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS